Status
Conditions
Treatments
About
In order to determine the acceptability of a breast cancer-specific cognitive behavioral therapy intervention, as well as to obtain preliminary data to assess efficacy in managing symptoms, the investigators will ask 45 breast cancer survivors with moderate insomnia, fatigue, and/or pain to use the investigators' internet-based intervention for 8 weeks and to complete patient-reported outcomes assessments before and after the 8 week intervention.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Female
Stage 0-III invasive carcinoma of the breast
Surgical resection and axillary assessment, radiation therapy, and/or chemotherapy, as indicated, completed at least 3 months prior to enrollment.
Concomitant trastuzumab and anti-endocrine therapies are permitted. If taking anti-endocrine therapy must have been taking for at least 3 months prior to enrollment.
Must report at least one of the following:
Has access to and is able to operate a computer with internet access.
Able to read and understand English.
Willing and able to sign an informed consent document.
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
45 participants in 3 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal